Clinical Leader Live: Are Decentralized Clinical Trials Cutting Costs at Clinical Sites?
The logistics of the COVID-19 pandemic directly impacted the ability of many pharma and biotech companies to perform research at traditional clinical trial sites. As a result, the use of decentralized clinical trials (DCTs) and hybrid format trials boomed. An episode from earlier this year covers how this has impacted traditional clinical sites and their staff.
Fierce Biotech Webinar: The ‘D’ in DCT stands for Decentralized
Decentralized trial (DCT) design has emerged in recent years and shaken up the clinical trial landscape. In an upcoming webinar [...]
Webinar – June 1st: Decentralized Clinical Trials in the Real World
Decentralization and digitization have accelerated changes in the clinical trials landscape. Uncertainty still surrounds this process, leaving sponsors and clinical [...]
Advertisement
